Earnings

Piramal Pharma Latest Results: Effective Tax Rate Elevated in FY27, Normalization to 24%-25% Ahead 1 min ago
Piramal Pharma disclosed during its concall that the effective tax rate will remain elevated in FY27, with normalization expected in the 24%-25% range as overseas operations scale up over the coming years. The elevated rate reflects the current developmental stage of the company's international business. No specific quarterly revenue or profit figures were provided in the available update.
no imag found
no imag found
Vinati Organics Latest Results: EBITDA Margin Guidance of 26-27% for FY27 1 min ago
no imag found
Syngene International Latest Results: Management guides FY27 EBITDA margin to mid-20% range 6 mins ago
no imag found
Vinati Organics Latest Results: ~15% Volume Growth Guided for FY27, Veeral to Add ₹400-500 Crore Revenue 6 mins ago
no imag found
Piramal Pharma Latest Results: May Revise FY27 Performance Guidance in Q2 10 mins ago

Today's Top Gainers

Bajaj Auto
11,506.50
(+1.49%)
Maruti Suzuki
14,015.00
(+0.48%)
Mahindra & Mahindra
3,283.00
(+1.90%)
UltraTech Cement
11,808.00
(+0.43%)
Eicher Motors
7,816.00
(+0.48%)

Today's Top Losers

Adani Ports & SEZ
1,674.60
(-2.62%)
Interglobe Aviation
5,231.50
(-0.85%)
Asian Paints
2,716.50
(-1.52%)
Larsen & Toubro
3,908.00
(-0.60%)
Shriram Finance
1,031.10
(-1.30%)

Today's Top Gainers

Bajaj Auto
11,506.50
(+1.49%)
Maruti Suzuki
14,015.00
(+0.48%)
Mahindra & Mahindra
3,283.00
(+1.90%)
UltraTech Cement
11,808.00
(+0.43%)
Eicher Motors
7,816.00
(+0.48%)

Today's Top Losers

Adani Ports & SEZ
1,674.60
(-2.62%)
Interglobe Aviation
5,231.50
(-0.85%)
Asian Paints
2,716.50
(-1.52%)
Larsen & Toubro
3,908.00
(-0.60%)
Shriram Finance
1,031.10
(-1.30%)

Earnings by Category

Piramal Pharma Latest Results: Effective Tax Rate Elevated in FY27, Normalization to 24%-25% Ahead 1 min ago
Piramal Pharma disclosed during its concall that the effective tax rate will remain elevated in FY27, with normalization expected in the 24%-25% range as overseas operations scale up over the coming years. The elevated rate reflects the current developmental stage of the company's international business. No specific quarterly revenue or profit figures were provided in the available update.
no imag found
no imag found
Piramal Pharma Latest Results: May Revise FY27 Performance Guidance in Q2 10 mins ago
no imag found
Star Health Latest Results: Projects 15-16% Insurance Revenue Growth for FY27 51 mins ago